|
|||||
|
|
Rates,factors, reasons,and economic impact associated with switching in rheumatoid arthritis patients newly initiated on biologic disease modifying anti-rheumatic drugs in an integrated healthcare system |
|
| Authors: | Nazia Rashid Antony T Lin Gustavus Aranda Jr Kathy J Lin Valerie N Guerrero Anagha Nadkarni |
| Institution: | 1. Kaiser Permanente, Southern California Region, Drug Information Services, Downey, CA, USA;2. nazia.x.rashid@kp.org;4. Southern California Permanente Medical Group, Kaiser Permanente Southern California, Fontana, CA, USA;5. Bristol-Myers Squibb, US Medical Health Services (Field), CA, USA;6. Bristol-Myers Squibb, US Medical, Plainsboro, NJ, USA |
| Abstract: | |
| Keywords: | Rheumatoid arthritis biologic DMARDS incident switching healthcare visits costs |